• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

呼吸道合胞病毒多肽抗体及其在人类感染中的意义。

Antibodies to respiratory syncytial virus polypeptides and their significance in human infection.

作者信息

Ward K A, Lambden P R, Ogilvie M M, Watt P J

出版信息

J Gen Virol. 1983 Sep;64 (Pt 9):1867-76. doi: 10.1099/0022-1317-64-9-1867.

DOI:10.1099/0022-1317-64-9-1867
PMID:6886679
Abstract

The human antibody response to respiratory syncytial (RS) virus infection was investigated using radioimmunoprecipitation analysis (RIPA). A total of nine RS virus-specific proteins, VP200, VGP95, VP68, VGP48, VPN41, VP35, VP27, VP23 and VGP20 were identified by comparing 35S- or 3H-labelled extracts of infected and uninfected HEp-2 cells, and by radioimmunoprecipitation using a hyperimmune human serum. Three glycopeptides, VGP95, VGP48 and VGP20, were identified by incorporation of [3H]glucosamine, and two of these (VGP48 and VGP20) were assumed to be part of a single disulphide-bonded polypeptide since they were precipitated by a monoclonal antibody raised against a surface protein. Human serum antibodies to three major RS virus proteins, VGP95, VGP48/VGP20 and VPN41 were measured by RIPA using radioiodinated RS virus antigens. Sera from a group of mothers whose babies escaped RS virus infection during a local epidemic showed increased antibody levels to VPN41 when compared to sera from mothers whose babies had become infected with RS virus within the first 6 months of life. In infants who remained uninfected with RS virus during the first 12 months of life the maternal gift of antibody decayed to about 50% at 3 months with traces of antibodies detected in a few sera at 12 months. The antibody levels detected in the sera of infants less than 3 months old convalescent from primary RS virus infection did not exceed the mean levels present in the serum of uninfected babies. Infants between the ages of 6 and 12 months were able to mount an IgG response to VPN41 and VGP48 but, unlike adults and older children, a particularly striking finding was their failure to produce antibodies to VGP95.

摘要

利用放射免疫沉淀分析(RIPA)研究了人类对呼吸道合胞(RS)病毒感染的抗体反应。通过比较感染和未感染的HEp-2细胞的35S或3H标记提取物,并使用超免疫人血清进行放射免疫沉淀,共鉴定出9种RS病毒特异性蛋白,即VP200、VGP95、VP68、VGP48、VPN41、VP35、VP27、VP23和VGP20。通过掺入[3H]葡糖胺鉴定出3种糖肽,即VGP95、VGP48和VGP20,其中两种(VGP48和VGP20)被认为是单一二硫键连接多肽的一部分,因为它们被针对表面蛋白产生的单克隆抗体沉淀。使用放射性碘化的RS病毒抗原,通过RIPA测定了人类血清中针对3种主要RS病毒蛋白VGP95、VGP48/VGP20和VPN41的抗体。与在生命的前6个月内婴儿感染RS病毒的母亲的血清相比,一组在当地疫情期间婴儿未感染RS病毒的母亲的血清显示出针对VPN41的抗体水平升高。在生命的前12个月内未感染RS病毒的婴儿中,母体给予的抗体在3个月时衰减至约50%,在12个月时在少数血清中检测到微量抗体。从原发性RS病毒感染中康复的3个月以下婴儿血清中检测到的抗体水平未超过未感染婴儿血清中的平均水平。6至12个月大的婴儿能够对VPN41和VGP48产生IgG反应,但与成人和大龄儿童不同的是,一个特别显著的发现是他们未能产生针对VGP95的抗体。

相似文献

1
Antibodies to respiratory syncytial virus polypeptides and their significance in human infection.呼吸道合胞病毒多肽抗体及其在人类感染中的意义。
J Gen Virol. 1983 Sep;64 (Pt 9):1867-76. doi: 10.1099/0022-1317-64-9-1867.
2
Immunoblot analysis of the human antibody response to respiratory syncytial virus infection.人对呼吸道合胞病毒感染的抗体反应的免疫印迹分析。
J Gen Virol. 1987 May;68 ( Pt 5):1267-75. doi: 10.1099/0022-1317-68-5-1267.
3
Maternal antibody and respiratory syncytial virus infection in infancy.婴儿期的母源抗体与呼吸道合胞病毒感染
J Med Virol. 1981;7(4):263-71. doi: 10.1002/jmv.1890070403.
4
Mammary immunity in mothers of infants with respiratory syncytial virus infection.呼吸道合胞病毒感染婴儿母亲的乳腺免疫
J Med Virol. 1987 Jul;22(3):277-87. doi: 10.1002/jmv.1890220312.
5
The response of infants with bronchiolitis to the proteins of respiratory syncytial virus.毛细支气管炎婴儿对呼吸道合胞病毒蛋白质的反应。
J Gen Virol. 1988 Jun;69 ( Pt 6):1229-39. doi: 10.1099/0022-1317-69-6-1229.
6
Preparation and characterization of monoclonal antibodies directed against five structural components of human respiratory syncytial virus subgroup B.针对人呼吸道合胞病毒B亚组五种结构成分的单克隆抗体的制备与鉴定
J Gen Virol. 1987 Dec;68 ( Pt 12):3125-35. doi: 10.1099/0022-1317-68-12-3125.
7
Prevalence of respiratory syncytial virus IgG antibodies in infants living in a rural area of Mozambique.莫桑比克农村地区婴儿呼吸道合胞病毒IgG抗体的流行情况。
J Med Virol. 2002 Aug;67(4):616-23. doi: 10.1002/jmv.10148.
8
Monoclonal antibodies to human respiratory syncytial virus and their use in comparison of different virus isolates.抗人呼吸道合胞病毒单克隆抗体及其在不同病毒分离株比较中的应用。
J Gen Virol. 1984 May;65 ( Pt 5):963-71. doi: 10.1099/0022-1317-65-5-963.
9
Detection of RS-virus IgG-subclass-specific antibodies: variation according to age in infants and small children and diagnostic value in RS-virus-infected small infants.呼吸道合胞病毒IgG亚类特异性抗体的检测:婴幼儿中的年龄差异及对呼吸道合胞病毒感染小婴儿的诊断价值
J Med Virol. 1985 Aug;16(4):329-35. doi: 10.1002/jmv.1890160405.
10
Monoclonal antibody-based capture enzyme immunoassays for specific serum immunoglobulin G (IgG), IgA, and IgM antibodies to respiratory syncytial virus.基于单克隆抗体的捕获酶免疫测定法,用于检测针对呼吸道合胞病毒的特异性血清免疫球蛋白G(IgG)、IgA和IgM抗体。
J Clin Microbiol. 1990 Dec;28(12):2744-9. doi: 10.1128/jcm.28.12.2744-2749.1990.

引用本文的文献

1
Clinical validation of an RSV neutralization assay and analysis of cross-sectional sera associated with 2021-2023 RSV outbreaks to investigate the immunity debt hypothesis.呼吸道合胞病毒(RSV)中和试验的临床验证以及对与2021 - 2023年RSV疫情相关的横断面血清的分析,以研究免疫债假说。
Microbiol Spectr. 2024 Oct 29;12(12):e0211524. doi: 10.1128/spectrum.02115-24.
2
Risk Factors of Very Severe RSV Infections in a Multicenter Cohort of Very Preterm and Extreme Preterm Babies Receiving or Not Palivizumab.在接受或未接受帕利珠单抗治疗的极早产儿和超极早产儿多中心队列中,极重度呼吸道合胞病毒感染的危险因素
Front Pediatr. 2022 Jul 7;10:884120. doi: 10.3389/fped.2022.884120. eCollection 2022.
3
Chapter 8 Paramyxoviruses.
第8章 副黏病毒
Perspect Med Virol. 1985;1:345-404. doi: 10.1016/S0168-7069(08)70016-8. Epub 2008 May 29.
4
[Not Available].[无可用内容]
EMC Pediatr. 2007;42(4):1-9. doi: 10.1016/S1245-1789(07)70240-8. Epub 2011 Aug 10.
5
[Not Available].[无可用内容]。
Ann Inst Pasteur Actual. 1995;6(1):23-29. doi: 10.1016/0924-4204(96)83603-1. Epub 2000 Apr 5.
6
Establishing Correlates of Protection for Vaccine Development: Considerations for the Respiratory Syncytial Virus Vaccine Field.建立疫苗研发的保护相关性:呼吸道合胞病毒疫苗领域的考量
Viral Immunol. 2018 Mar;31(2):195-203. doi: 10.1089/vim.2017.0147. Epub 2018 Jan 16.
7
Development of a luciferase immunoprecipitation system assay to detect IgG antibodies against human respiratory syncytial virus nucleoprotein.用于检测抗人呼吸道合胞病毒核蛋白IgG抗体的荧光素酶免疫沉淀系统检测方法的开发。
Clin Vaccine Immunol. 2014 Mar;21(3):383-90. doi: 10.1128/CVI.00594-13. Epub 2014 Jan 8.
8
The level and duration of RSV-specific maternal IgG in infants in Kilifi Kenya.肯尼亚基利菲婴儿中 RSV 特异性母体 IgG 的水平和持续时间。
PLoS One. 2009 Dec 2;4(12):e8088. doi: 10.1371/journal.pone.0008088.
9
Priming with secreted glycoprotein G of respiratory syncytial virus (RSV) augments interleukin-5 production and tissue eosinophilia after RSV challenge.用呼吸道合胞病毒(RSV)分泌的糖蛋白G进行预刺激可增强RSV攻击后白细胞介素-5的产生和组织嗜酸性粒细胞增多。
J Virol. 1998 Apr;72(4):2871-80. doi: 10.1128/JVI.72.4.2871-2880.1998.
10
Prevalence of antibodies against HEp-2 cell antigen in infants and children hospitalized with respiratory syncytial virus infection.呼吸道合胞病毒感染住院婴幼儿及儿童中抗HEp-2细胞抗原抗体的流行情况。
Infection. 1996 Nov-Dec;24(6):407-11. doi: 10.1007/BF01713039.